Skip to main contentSkip to navigationSkip to search

Press release

Camurus to present at the J.P. Morgan Annual Healthcare Conference 2017

09 January 2017

Lund — 9 January 2017 — Camurus AB (Nasdaq Stockholm; CAMX) today announces that that the Company will present at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco, CA, at 11:30 am Pacific time on January 12, 2017. Fredrik Tiberg, President and CEO, will provide a company overview including an update on the progress of the development pipeline.

About Camurus
Camurus is a Swedish research-based pharmaceutical company committed to developing and commercialising innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products with best-in-class potential are conceived based on the proprietary FluidCrystal® drug delivery technologies and an extensive R&D expertise. Camurus’ clinical pipeline includes products for treatment of cancer, endocrine diseases, pain and addiction, developed in-house and in collaboration with international pharmaceutical companies. The company’s shares are listed on Nasdaq Stockholm under the ticker “CAMX”. For more information, visit

For more information
Fredrik Tiberg, President & CEO
Tel. +46 (0)46 286 46 92

Rein Piir, VP Investor Relations
Tel. +46 (0)70 853 72 92

The information was submitted for publication at 08.00 a.m. on 9 January 2017.

TypeError: Cannot read properties of undefined (reading 'url')